Sandoz Expands Antibiotics Production with New Austrian Factory
Sandoz (OTCMKTS: SDZNY), a Swiss pharmaceutical company, has announced the opening of a new antibiotics...
Shanghai Institute’s Biosimilar Rituximab Approved by NMPA for Lymphoma Treatments
Shanghai Institute of Biological Products Co., Ltd has announced that its biosimilar version of Roche/Genentech’s...
EMA Panel Backs Novartis’s Fabhalta for PNH Treatment, Awaits EC Decision
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA)...
Sumitomo Pharma’s China CEO Highlights Strategic Importance of Local Market
Yoshitaka Koketsu, CEO of Sumitomo Pharma (TYO: 4506) (China) Co., Ltd, the Chinese subsidiary of...
Roche Invests EUR 90 Million in New Gene Therapy Center in Germany
Swiss pharmaceutical giant Roche (SWX: RO) has inaugurated a new gene therapy development center in...
Sanofi Projects EUR 13 Billion in Dupixent Sales for 2024 Despite Q1 Challenges
Sanofi (NASDAQ: SNY), a leading French pharmaceutical company, has released its guidance for the first...
FibroGen’s Roxadustat Approved in Macau for Chronic Kidney Disease-Related Anemia
FibroGen Inc. (NASDAQ: FGEN), a biopharmaceutical company based in the US, has announced that it...
China’s Commerce Minister Meets with Global Pharma Leaders to Discuss Innovation Cooperation
China’s Minister of Commerce, Wang Wentao, convened a high-level meeting with top executives from the...
Yifan Pharmaceutical’s F-627 Approved by European Commission for Marketing in EU
Yifan Pharmaceutical Co., Ltd (SHE: 002019), a Chinese pharmaceutical company, has announced that its subsidiary...
OBiO Technology Partners with Saierxin Bio to Support Treg Cell Therapy Development
OBiO Technology (Shanghai) Co., Ltd (SHA: 688238), a Chinese Contract Research Organization (CRO) specializing in...
Grand Pharma Receives NMPA Approval for Global Phase III Study of RDC ITM-11 in GEP-NETs
Grand Pharmaceutical Group Ltd (HKG: 0512), a leading pharmaceutical company based in China, has announced...
Jenscare Scientific Completes Enrollment in Clinical Study for Mitral Valve Repair System
Jenscare Scientific Co., Ltd (HKG: 9877), a leading structural heart disease device manufacturer headquartered in...
Zhejiang Dian Diagnostics Partners with Haihe Laboratory to Advance Hematology Diagnostics
Zhejiang Dian Diagnostics Co., Ltd (SHE: 300244), a company based in China, has entered into...
Golden Leaf Med Tec Secures Series D Funding to Advance Hypertension and Diabetes Treatments
Shanghai Golden Leaf Med Tec Co., Ltd, a specialist in interventional treatments based in China,...
Joincare Pharmaceuticals Secures Rights to Bayer’s Respiratory Drug in China
Joincare Pharmaceutical Group Industry Co., Ltd (SHA: 600380), a Chinese pharmaceutical company, has announced a...
AriBio Expands Alzheimer’s Drug AR1001 Licensing Deal with Samjin to Include China
AriBio Co., Ltd, a South Korea-based pharmaceutical company, has announced an expansion of its previous...
Sino Biological Partners with Rapid Novor to Market mAb Sequencing Services Across Asia
Sino Biological Inc. (SHE: 301047), a leading supplier of reagents based in China, has announced...
Lynk Pharmaceuticals Doses First Patient in Phase III Trial for Atopic Dermatitis Treatment
Lynk Pharmaceuticals Co., Ltd, based in China, has announced the dosing of the first patient...
HutchMed Launches Phase II/III Study for Sovleplenib in Autoimmune Hemolytic Anemia
HutchMed (China) Ltd (NASDAQ: HCM; HKG: 0013) has announced the initiation of the Phase II/III...
NeuExcell Therapeutics Doses First Patient in Groundbreaking Clinical Trial for NeuroD1 Gene Therapy
NeuExcell Therapeutics, a Shanghai-based developer of in vivo neural regenerative therapies, has announced the first...